Literature DB >> 30738280

Incidence of multiple sclerosis misdiagnosis in referrals to two academic centers.

Marwa Kaisey1, Andrew J Solomon2, Michael Luu2, Barbara S Giesser2, Nancy L Sicotte2.   

Abstract

BACKGROUND: Multiple Sclerosis (MS) specialists routinely evaluate misdiagnosed patients, or patients incorrectly assigned a diagnosis of MS. Misdiagnosis has significant implications for patient morbidity and healthcare costs, yet its contemporary incidence is unknown. We examined the incidence of MS misdiagnosis in new patients referred to two academic MS referral centers, their most common alternate diagnoses, and factors associated with misdiagnosis.
METHODS: Demographic data, comorbidities, neurological examination findings, radiographic and laboratory results, a determination of 2010 McDonald Criteria fulfillment, and final diagnoses were collected from all new patient evaluations completed at the Cedars-Sinai Medical Center and the University of California, Los Angeles MS clinics over twelve months.
RESULTS: Of the 241 new patients referred with an established diagnosis of MS, 17% at Cedars-Sinai and 19% at UCLA were identified as having been misdiagnosed. The most common alternative diagnoses were migraine (16%), radiologically isolated syndrome (9%), spondylopathy (7%), and neuropathy (7%). Clinical syndromes and radiographic findings atypical for MS were both associated with misdiagnosis. The misdiagnosed group received approximately 110 patient-years of unnecessary MS disease modifying therapy.
CONCLUSION: MS misdiagnosis is common; in our combined cohort, almost 1 in 5 patients who carried an established diagnosis of MS did not fulfill contemporary McDonald Criteria and had a more likely alternate diagnosis.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Diagnosis; Diagnostic errors; Multiple sclerosis

Mesh:

Year:  2019        PMID: 30738280     DOI: 10.1016/j.msard.2019.01.048

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN: 2211-0348            Impact factor:   4.339


  18 in total

1.  Predicting onset of secondary-progressive multiple sclerosis using genetic and non-genetic factors.

Authors:  Elina Misicka; Corriene Sept; Farren B S Briggs
Journal:  J Neurol       Date:  2020-04-24       Impact factor: 4.849

Review 2.  From the prodromal stage of multiple sclerosis to disease prevention.

Authors:  Ruth Ann Marrie; Mark Allegretta; Lisa F Barcellos; Bruce Bebo; Peter A Calabresi; Jorge Correale; Benjamin Davis; Philip L De Jager; Christiane Gasperi; Carla Greenbaum; Anne Helme; Bernhard Hemmer; Pamela Kanellis; Walter Kostich; Douglas Landsman; Christine Lebrun-Frenay; Naila Makhani; Kassandra L Munger; Darin T Okuda; Daniel Ontaneda; Ronald B Postuma; Jacqueline A Quandt; Sharon Roman; Shiv Saidha; Maria Pia Sormani; Jon Strum; Pamela Valentine; Clare Walton; Kathleen M Zackowski; Yinshan Zhao; Helen Tremlett
Journal:  Nat Rev Neurol       Date:  2022-07-15       Impact factor: 44.711

3.  Lesion size and shape in central vein sign assessment for multiple sclerosis diagnosis: An in vivo and postmortem MRI study.

Authors:  Omar Al-Louzi; Sargis Manukyan; Maxime Donadieu; Martina Absinta; Vijay Letchuman; Brent Calabresi; Parth Desai; Erin S Beck; Snehashis Roy; Joan Ohayon; Dzung L Pham; Anish Thomas; Steven Jacobson; Irene Cortese; Pavan K Auluck; Govind Nair; Pascal Sati; Daniel S Reich
Journal:  Mult Scler       Date:  2022-06-08       Impact factor: 5.855

Review 4.  Multiple Sclerosis: Systemic Challenges to Cost-Effective Care.

Authors:  David R Weinstein; Gary M Owens; Ankit Gandhi
Journal:  Am Health Drug Benefits       Date:  2022-03

Review 5.  An Update on Diagnostic Laboratory Biomarkers for Multiple Sclerosis.

Authors:  Marwa Kaisey; Ghazal Lashgari; Justyna Fert-Bober; Daniel Ontaneda; Andrew J Solomon; Nancy L Sicotte
Journal:  Curr Neurol Neurosci Rep       Date:  2022-10-21       Impact factor: 6.030

Review 6.  Pathology-supported genetic testing as a method for disability prevention in multiple sclerosis (MS). Part I. Targeting a metabolic model rather than autoimmunity.

Authors:  Susan J van Rensburg; Ronald van Toorn; Rajiv T Erasmus; Coenraad Hattingh; Clint Johannes; Kelebogile E Moremi; Merlisa C Kemp; Penelope Engel-Hills; Maritha J Kotze
Journal:  Metab Brain Dis       Date:  2021-04-28       Impact factor: 3.584

7.  The impact of socioeconomic status on mental health and health-seeking behavior across race and ethnicity in a large multiple sclerosis cohort.

Authors:  Daniela A Pimentel Maldonado; Justin R Eusebio; Lilyana Amezcua; Eleni S Vasileiou; Ellen M Mowry; Christopher C Hemond; Raffaella Umeton Pizzolato; Idanis Berrios Morales; Irina Radu; Carolina Ionete; Kathryn C Fitzgerald
Journal:  Mult Scler Relat Disord       Date:  2021-12-05       Impact factor: 4.808

Review 8.  Molecular Biomarkers in Multiple Sclerosis and Its Related Disorders: A Critical Review.

Authors:  Maryam Gul; Amirhossein Azari Jafari; Muffaqam Shah; Seyyedmohammadsadeq Mirmoeeni; Safee Ullah Haider; Sadia Moinuddin; Ammar Chaudhry
Journal:  Int J Mol Sci       Date:  2020-08-21       Impact factor: 5.923

9.  Online Resources to Boost Radiological Skills Among Trainees.

Authors:  Nara Miriam Michaelson; Andrew D Schweitzer; J Levi Chazen; Matthew S Robbins
Journal:  J Grad Med Educ       Date:  2021-02-13

10.  Is there an association between multiple sclerosis and osteoarthritis in Germany? A retrospective cohort study of 8,600 patients from Germany.

Authors:  Louis Jacob; Lee Smith; Ai Koyanagi; Josep Maria Haro; Marcel Konrad; Christian Tanislav; Karel Kostev
Journal:  Mult Scler J Exp Transl Clin       Date:  2021-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.